This inventor holds 2 USPTO granted patents. Top assignee: Xiamen LP Pharmaceutical Co., Ltd.. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Innovations by Yong Yu in Pharmaceutical Technology
Introduction
Yong Yu is a notable inventor based in Xiamen, China, recognized for his contributions to pharmaceutical technology. He holds two patents that showcase his innovative approach to drug formulation, particularly in the development of oral soluble films.
Latest Patents
Yong Yu's latest patents focus on the preparation of aripiprazole oral soluble films. The first patent describes a method for creating an aripiprazole oral soluble film that contains 10-60% w/w of aripiprazole in a crystalline state and 30-95% w/w of one or more film-forming materials. The film is designed to ensure that 90% of the aripiprazole particles are sized at or below 14.3 micrometers, allowing for a uniform blend without visible undispersed particles. This formulation is noted for its excellent bioavailability, uniformity, stability, and palatability. The preparation process involves grinding aripiprazole particles to achieve the desired size, blending them with film-forming materials in an aqueous solution, defoaming the mixture, and then coating and drying it to form the final film.
Career Highlights
Yong Yu is currently employed at Xiamen LP Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has significantly impacted the way certain medications are delivered, enhancing patient compliance and therapeutic outcomes.
Collaborations
Yong Yu collaborates with talented coworkers, including Rongbin Ling and Lingyu Cai, who contribute to the research and development efforts at their company.
Conclusion
Yong Yu's innovative work in developing aripiprazole oral soluble films exemplifies the advancements being made in pharmaceutical technology. His contributions are paving the way for improved medication delivery systems that benefit patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile